Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 8INDUSTRY 4NIH 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Breast 1

Conditions

Breast Neoplasms 6Prostatic Neoplasms 2Pain 2Osteoporosis 2Neoplasm Metastasis 2Sarcoma 1Ovarian Neoplasms 1Osteosarcoma 1Lung Neoplasms 1Humoral Hypercalcemia Of Malignancy 1Hereditary Breast and Ovarian Cancer Syndrome 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Absorptiometry, Photon 4Zoledronic Acid 2Risedronic Acid 2Vitamin D 1Spectrum Analysis 1Radiotherapy 1Gonadotropin-Releasing Hormone 1Cholecalciferol 1Calcium Gluconate 1Calcium Citrate 1Calcium Carbonate 1Calcium 1Alendronate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Osteoporosis × Zoledronic Acid × Clear all
NCT00305695 2020-03-24

Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries

GOG Foundation

Phase 2 Completed
160 enrolled 10 charts
BreastGynecologic

Osteoporosis, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT00329797 2017-11-29

Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy

Radiation Therapy Oncology Group

Phase 3 Completed
109 enrolled 8 charts
Genitourinary

Osteoporosis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡